LB Pharmaceuticals Inc is seeking institutional investment for a private placement, utilizing Leerink Partners as the placement agent, with BB Biotech as a key entity.
1 report, 1 independent
Updated Jul 29
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
LB Pharmaceuticals Inc is seeking institutional investment for a private placement, utilizing Leerink Partners as the placement agent, with BB Biotech as a key entity.
Who's involved
What this event is mainly aboutBB BiotechLeerink partners
How it developed
Newest first. Tap a step to see who reported it.- Leerink partners began its role as the lead book-running manager for an offering on behalf of BlossomHill Therapeutics, Inc. on August 1, 2026.Sub-event
LB Pharmaceuticals Inc is seeking institutional investment for a private placement, using Leerink Partners as the placement agent.1 source
Keep exploring
The entities involved
-
Leerink partners
U.S. investment bank